- Home
- MKDW vs ACRV Comparison
MKDW vs ACRV Comparison
Compare MKDW & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- ACRV
- Stock Information
- Founded
- MKDW 2006
- ACRV 2018
- Country
- MKDW Taiwan
- ACRV United States
- Employees
- MKDW N/A
- ACRV N/A
- Industry
- MKDW
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- MKDW
- ACRV Health Care
- Exchange
- MKDW NYSE
- ACRV Nasdaq
- Market Cap
- MKDW 34.3M
- ACRV 40.4M
- IPO Year
- MKDW N/A
- ACRV 2022
- Fundamental
- Price
- MKDW $0.23
- ACRV $1.33
- Analyst Decision
- MKDW
- ACRV Buy
- Analyst Count
- MKDW 0
- ACRV 7
- Target Price
- MKDW N/A
- ACRV $17.60
- AVG Volume (30 Days)
- MKDW 1.3M
- ACRV 301.1K
- Earning Date
- MKDW 08-12-2025
- ACRV 08-12-2025
- Dividend Yield
- MKDW N/A
- ACRV N/A
- EPS Growth
- MKDW N/A
- ACRV N/A
- EPS
- MKDW N/A
- ACRV N/A
- Revenue
- MKDW $3,670,722.00
- ACRV N/A
- Revenue This Year
- MKDW N/A
- ACRV N/A
- Revenue Next Year
- MKDW N/A
- ACRV N/A
- P/E Ratio
- MKDW N/A
- ACRV N/A
- Revenue Growth
- MKDW 16.40
- ACRV N/A
- 52 Week Low
- MKDW $0.17
- ACRV $1.05
- 52 Week High
- MKDW $5.52
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- ACRV 49.19
- Support Level
- MKDW N/A
- ACRV $1.34
- Resistance Level
- MKDW N/A
- ACRV $1.48
- Average True Range (ATR)
- MKDW 0.00
- ACRV 0.08
- MACD
- MKDW 0.00
- ACRV 0.01
- Stochastic Oscillator
- MKDW 0.00
- ACRV 37.04
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.